Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-388-0 | CAS number: 12067-23-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
A reproduction and development toxicity screening study according to OECD guideline 421 in rats with tin sulfide revealed the following values:
NOAEL for the Reproduction: 1000 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of males: 300 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of females: 1000 mg/kg bw/day,
NOAEL for the Development of pups: 1000 mg/kg bw/day.
Based on this information it is considered that also ditin trisulfide reveals no reproduction and developmental toxicity. The calculated NOAEL for reproduction and development is 1106 mg/kg bw/day.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Read-Across Justification_SnS and SnS2 to Sn2S3
- Reason / purpose for cross-reference:
- read-across source
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Males:
No treatment-related effects were found in treated males during the health condition control.
No relevant clinical changes were observed in males at all dose levels after application of the test substance.
Slight fall of weight ( one male at the dose level of 100 mg/kg/day in the 6th week) and thinner excrements ( one male at the dose of 1000 mg/kg/day in the 1 st week) were observed sporadically in treated males.
Females:
Slight decreases in body weights were sporadically (in 1 or 2 females from the group) recorded in the 3rd week at all groups including control.
In treated females of all dose levels, no signs of disease were found during the check-in, acclimatisation and application period. Treatment-related effects were not detected during health condition control and clinical observation of females ( except of vocalisation in one female at the dose level of 1000 mg/kg/day in the 5th week). - Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Description (incidence):
- There were no unscheduled deaths during the study.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- The average animal body weights at all dose levels were relatively balanced with the control group during the whole application period. No statistically significant differences were detected.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- Males: Average food consumption values of males at all treated close levels were slightly increased against the control group during the whole study. These differences were not dependent on the dose level and therefore not considered relevant.
Fermales:
Females:
Pre-mating period
Average food consumption of treated females was analogous to food consumption of control females.
Pregnancy
Females without parturition (non pregnant or aborted females) were not included in the evaluation of food consumption during pregnancy. Average food consumption of treated females was well-balanced with control females.
Lactation
Only mothers (females with live pups) were included in evaluation of food consumption during lactation period. Average food consumption of treated females was similar to consumption of control females. - Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- The effect on the microscopical structure of the testes (sporadic degeneration and/or atrophy of germ epithelium, residual bodies in germ epithelium and vacuolation of cytoplasm of spermiogonia) had no effect on spermiogenesis, thus, were not relevant.
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- no effects observed
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- for the REPRODUCTION
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Systemic toxicity
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- toxic effect on reproduction organs
- Effect level:
- 300 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- organ weights and organ / body weight ratios
- histopathology: non-neoplastic
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- toxic effect on reproduction organs
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- reproductive performance
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- One pup of control group and one pup of the dose level 300 mg/kg/day died after birth – in the period 0/1st day - 4th day.
No differences in development of pups were observed at the control group and at all treated groups.
Statistical evaluation was performed on the number of live pups.
The total numbers of live pups (on the day of parturition/1st day after parturition and the 4th day after parturition) were similar at the control and the dose level 1000 mg/kg. At the dose level 100 mg/kg/day the number was higher, and vice versa at the dose level 300 mg/kg/day, it was slightly lower.
Average numbers of pups per litter were well-balanced at the control and the dose level 100 mg/kg/day. At the dose levels 300 and 1000 mg/kg/day, the average number of pups per litter was decreased compared to the control, however they fell within the normal range of historical control data. - Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- The average weights of the litters and pups at the dose level 100 mg/kg/day were slightly increased against control. At the dose levels of 300 and 1000 mg/kg/day, the average weight of the litter was lower compared to control, but the average body weights of pups were slightly higher compared to control group. No statistically significant changes were found.
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- The macroscopical examination was performed in all pups. Sporadic pathologic findings were recorded in pups of the treated and control groups. The number of pups with macroscopic changes was comparable in the control and 100 and 300 mg/kg dosed groups; an increase in livers with marked structure was noted in the 1000 mg/kg dose group.
- Histopathological findings:
- no effects observed
- Description (incidence and severity):
- The microscopical examination was performed in the pups with macroscopic changes: susp. hydrocephalus (litter No. 142 at the dose level 300) - no histopathological changes in cranial cavity; dark spot on testis (litter No. 167 at the dose level 1000) - no histopathological changes on testis and epididymis; oversized teeth (litter No. 127 at the dose level 100) – no histopathological changes and marked structure of liver (litter No. 164 and 171 at the dose level 1000) – extramedullary haemopoiesis was recorded (it is a physiological finding in pups).
- Behaviour (functional findings):
- not examined
- Developmental immunotoxicity:
- not examined
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- for the development
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- clinical signs
- mortality
- body weight and weight gain
- gross pathology
- Reproductive effects observed:
- not specified
- Conclusions:
- A reproduction and development toxicity screening study according to OECD guideline 421 in rats with tin sulfide revealed the following values:
NOAEL for the Reproduction: 1000 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of males: 300 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of females: 1000 mg/kg bw/day,
NOAEL for the Development of pups: 1000 mg/kg bw/day.
Based on this information it is considered that also ditin trisulfide reveals no reproduction and developmental toxicity. The calculated NOAEL for reproduction and development is 1106 mg/kg bw/day. - Executive summary:
A reproduction and development toxicity screening study according to OECD guideline 421 in rats with read-across substance tin sulfide revealed the following values:
NOAEL for the Reproduction: 1000 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of males: 300 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of females: 1000 mg/kg bw/day,
NOAEL for the Development of pups: 1000 mg/kg bw/day.
The irrelevant negative influence of the read-across test substance treatment expressed in males of the highest dose level (limit dose) consisted of an increase in absolute weight of pituitary gland (without histopathological changes) and an effect on the microscopical structure of the testes (sporadic occurrence of degeneration and/or atrophy of germ epithelium, residual bodies in germ epithelium and vacuolation of cytoplasm of spermiogonia) without effect on the spermiogenesis. Moreover, there were no histopathological findings in testes in a 90-day study on tin sulfide. The average number of pups and accompanied weight of the litters varied among groups, but fell withing historical ranges and these differences were not considered to be toxicologically relevant.
Body weight, food consumption, clinical observations, weight of reproductive organs of parental males were not markedly affected by treatment of the test substance. Body weight, food consumption, clinical observations, organ weights and structure of reproductive organs of parental females were also not adversely affected by treatment of the test substance. Reproductive performance - ability of male and female animals to successfully mate and produce viable offspring was unaffected by the test substance treatment. Also sex ratio and development of pups were not changed in treated groups.
Based on this information it is considered that also ditin trisulfide reveals no reproduction and developmental toxicity. The calculated NOAEL for reproduction and development is 1106 mg/kg bw/day.
Reference
Reproduction parameters - number of females achieving pregnancy, number of females bearing live pups and number of females with live pups at day 4 after parturition in treated groups were similar to the control or higher than the control groups. Duration of mating and pregnancy were similar in the control and treated females. Pre-implantation, post-implantation and postnatal losses were relatively well balanced at the treated groups and control group.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 106 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
A reproduction and development toxicity screening study according to OECD guideline 421 in rats with read-across substance tin sulfide revealed the following values:
NOAEL for the Reproduction: 1000 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of males: 300 mg/kg bw/day,
NOEL for the toxic effect on reproduction organs of females: 1000 mg/kg bw/day,
NOAEL for the Development of pups: 1000 mg/kg bw/day.
The irrelevant negative influence of the read-across test substance treatment expressed in males of the highest dose level (limit dose) consisted of an increase in absolute weight of pituitary gland (without histopathological changes) and an effect on the microscopical structure of the testes (sporadic occurrence of degeneration and/or atrophy of germ epithelium, residual bodies in germ epithelium and vacuolation of cytoplasm of spermiogonia) without effect on the spermiogenesis. Moreover, there were no histopathological findings in testes in a 90-day study on tin sulfide. The average number of pups and accompanied weight of the litters varied among groups, but fell withing historical ranges and these differences were not considered to be toxicologically relevant.
Body weight, food consumption, clinical observations, weight of reproductive organs of parental males were not markedly affected by treatment of the test substance. Body weight, food consumption, clinical observations, organ weights and structure of reproductive organs of parental females were also not adversely affected by treatment of the test substance. Reproductive performance - ability of male and female animals to successfully mate and produce viable offspring was unaffected by the test substance treatment. Also sex ratio and development of pups were not changed in treated groups.
Based on this information it is considered that also ditin trisulfide reveals no reproduction and developmental toxicity. The calculated NOAEL for reproduction and development is 1106 mg/kg bw/day.
Justification for selection of Effect on fertility via oral route:
GLP and guideline compliant study on a structural analogous read-across substance
Effects on developmental toxicity
Description of key information
Referring to the results of OECD 421 study on tin sulfide, there is no evidence that tin sulfides in general are causing any developmental as well as teratogenetical toxicity. After detailed checking literature situation, even there is no evidence found in epidemiological studies.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of the available studies on tin sulfide, ditin trisulfide is not subject to classification as reproductive toxic according to the criteria of EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.